Glucotrack Stock Market Value
| GCTK Stock | USD 0.26 0.01 4.00% |
| Symbol | GlucoTrack |
GlucoTrack Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Return On Assets (1.57) | Return On Equity (5.41) |
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GlucoTrack 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GlucoTrack's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GlucoTrack.
| 08/28/2024 |
| 11/26/2024 |
If you would invest 0.00 in GlucoTrack on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding GlucoTrack or generate 0.0% return on investment in GlucoTrack over 90 days. GlucoTrack is related to or competes with Heartbeam, EUDA Health, Nutex Health, Healthcare Triangle, Mangoceuticals, Common, and Aclarion. GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring device... More
GlucoTrack Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GlucoTrack's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GlucoTrack upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 90.86 | |||
| Value At Risk | (13.89) | |||
| Potential Upside | 10.4 |
GlucoTrack Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GlucoTrack's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GlucoTrack's standard deviation. In reality, there are many statistical measures that can use GlucoTrack historical prices to predict the future GlucoTrack's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (2.44) | |||
| Total Risk Alpha | (3.94) | |||
| Treynor Ratio | (0.70) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlucoTrack's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GlucoTrack Backtested Returns
GlucoTrack holds Efficiency (Sharpe) Ratio of -0.19, which attests that the entity had a -0.19% return per unit of risk over the last 3 months. GlucoTrack exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GlucoTrack's Standard Deviation of 11.8, risk adjusted performance of (0.13), and Market Risk Adjusted Performance of (0.69) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.96, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GlucoTrack will likely underperform. At this point, GlucoTrack has a negative expected return of -2.3%. Please make sure to check out GlucoTrack's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if GlucoTrack performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.79 |
Good predictability
GlucoTrack has good predictability. Overlapping area represents the amount of predictability between GlucoTrack time series from 28th of August 2024 to 12th of October 2024 and 12th of October 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GlucoTrack price movement. The serial correlation of 0.79 indicates that around 79.0% of current GlucoTrack price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.55 |
GlucoTrack lagged returns against current returns
Autocorrelation, which is GlucoTrack stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GlucoTrack's stock expected returns. We can calculate the autocorrelation of GlucoTrack returns to help us make a trade decision. For example, suppose you find that GlucoTrack has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GlucoTrack regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GlucoTrack stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GlucoTrack stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GlucoTrack stock over time.
Current vs Lagged Prices |
| Timeline |
GlucoTrack Lagged Returns
When evaluating GlucoTrack's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GlucoTrack stock have on its future price. GlucoTrack autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GlucoTrack autocorrelation shows the relationship between GlucoTrack stock current value and its past values and can show if there is a momentum factor associated with investing in GlucoTrack.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out GlucoTrack Correlation, GlucoTrack Volatility and GlucoTrack Alpha and Beta module to complement your research on GlucoTrack. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
GlucoTrack technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.